1. Home
  2. SWX vs BLCO Comparison

SWX vs BLCO Comparison

Compare SWX & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Southwest Gas Holdings Inc. (DE)

SWX

Southwest Gas Holdings Inc. (DE)

N/A

Current Price

$86.84

Market Cap

6.7B

Sector

Utilities

ML Signal

N/A

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

N/A

Current Price

$17.24

Market Cap

6.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SWX
BLCO
Founded
1931
1853
Country
United States
Canada
Employees
N/A
N/A
Industry
Oil & Gas Production
Ophthalmic Goods
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.7B
6.1B
IPO Year
2017
2022

Fundamental Metrics

Financial Performance
Metric
SWX
BLCO
Price
$86.84
$17.24
Analyst Decision
Strong Buy
Buy
Analyst Count
5
11
Target Price
$87.40
$18.45
AVG Volume (30 Days)
386.4K
400.3K
Earning Date
05-05-2026
04-29-2026
Dividend Yield
2.70%
N/A
EPS Growth
120.29
N/A
EPS
2.49
N/A
Revenue
$5,433,972,000.00
$5,101,000,000.00
Revenue This Year
$18.48
$8.65
Revenue Next Year
$2.61
$5.59
P/E Ratio
$34.58
N/A
Revenue Growth
9.56
6.47
52 Week Low
$76.74
$13.77
52 Week High
$94.47
$18.92

Technical Indicators

Market Signals
Indicator
SWX
BLCO
Relative Strength Index (RSI) 36.30 55.37
Support Level $83.99 $16.26
Resistance Level $86.75 $17.82
Average True Range (ATR) 1.54 0.46
MACD -0.31 -0.05
Stochastic Oscillator 7.88 41.97

Price Performance

Historical Comparison
SWX
BLCO

About SWX Southwest Gas Holdings Inc. (DE)

Southwest Gas Holdings Inc is a utility company engaged in the purchasing, distributing, and transporting of natural gas in the American Southwest. The company segments its activities into natural gas distribution segment. The Natural gas distribution segment encompasses the company's core natural gas business as distributors in the states of Arizona and Nevada. Its division is responsible for roughly half of Southwest Gas' total revenue through the sale of natural gas to mainly residential and small commercial customers.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: